254 related articles for article (PubMed ID: 15454175)
41. Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart failure.
Price JF; Towbin JA; Dreyer WJ; Moffett BS; Kertesz NJ; Clunie SK; Denfield SW
J Card Fail; 2006 Mar; 12(2):139-43. PubMed ID: 16520263
[TBL] [Abstract][Full Text] [Related]
42. Safety and feasibility of inpatient exercise training in pediatric heart failure: a preliminary report.
McBride MG; Binder TJ; Paridon SM
J Cardiopulm Rehabil Prev; 2007; 27(4):219-22. PubMed ID: 17667017
[TBL] [Abstract][Full Text] [Related]
43. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
[TBL] [Abstract][Full Text] [Related]
44. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
[TBL] [Abstract][Full Text] [Related]
45. Slow induction of milrinone after coronary artery bypass grafting.
Shibata T; Suehiro S; Sasaki Y; Hosono M; Nishi S; Kinoshita H
Ann Thorac Cardiovasc Surg; 2001 Feb; 7(1):23-7. PubMed ID: 11343562
[TBL] [Abstract][Full Text] [Related]
46. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators.
Ermis C; Zhu AX; Vanheel L; Sakaguchi RN; Lurie KG; Lu F; Benditt DG
Europace; 2007 May; 9(5):270-4. PubMed ID: 17371804
[TBL] [Abstract][Full Text] [Related]
47. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Zaman S; Sivagangabalan G; Narayan A; Thiagalingam A; Ross DL; Kovoor P
Circulation; 2009 Jul; 120(3):194-200. PubMed ID: 19581496
[TBL] [Abstract][Full Text] [Related]
48. Acceptance of a pump-driven infusion therapy with prostaglandin E1 as a bridge to heart transplantation.
Daneschvar H; Pacher R; Rödler S; Stanek B; Hülsmann M; Grimm M; Laufer G; Wolner E; Bunzel B
Wien Klin Wochenschr; 1996; 108(16):510-4. PubMed ID: 8840497
[TBL] [Abstract][Full Text] [Related]
49. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
50. Safety of Outpatient Milrinone Infusion in End-Stage Heart Failure: ICD-Level Data on Atrial Fibrillation and Ventricular Tachyarrhythmias.
Harhash AA; Cassuto J; Hussein A; Achu E; Zucker MJ; Goldschmidt M; Alpert JS; Baran DA
Am J Med; 2020 Jul; 133(7):857-864. PubMed ID: 31883773
[TBL] [Abstract][Full Text] [Related]
51. Milrinone increases flow in coronary artery bypass grafts after cardiopulmonary bypass: a prospective, randomized, double-blind, placebo-controlled study.
Arbeus M; Axelsson B; Friberg O; Magnuson A; Bodin L; Hultman J
J Cardiothorac Vasc Anesth; 2009 Feb; 23(1):48-53. PubMed ID: 18834820
[TBL] [Abstract][Full Text] [Related]
52. Milrinone for long-term pharmacologic support of the status 1 heart transplant candidates.
Canver CC; Chanda J
Ann Thorac Surg; 2000 Jun; 69(6):1823-6. PubMed ID: 10892930
[TBL] [Abstract][Full Text] [Related]
53. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.
Ermis C; Seutter R; Zhu AX; Benditt LC; VanHeel L; Sakaguchi S; Lurie KG; Lu F; Benditt DG
J Am Coll Cardiol; 2005 Dec; 46(12):2258-63. PubMed ID: 16360055
[TBL] [Abstract][Full Text] [Related]
54. Intravenous home inotropic use is safe in pediatric patients awaiting transplantation.
Birnbaum BF; Simpson KE; Boschert TA; Zheng J; Wallendorf MJ; Schechtman K; Canter CE
Circ Heart Fail; 2015 Jan; 8(1):64-70. PubMed ID: 25472966
[TBL] [Abstract][Full Text] [Related]
55. Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy.
Acharya D; Sanam K; Revilla-Martinez M; Hashim T; Morgan CJ; Pamboukian SV; Loyaga-Rendon RY; Tallaj JA
Am J Cardiol; 2016 Mar; 117(6):952-6. PubMed ID: 26810859
[TBL] [Abstract][Full Text] [Related]
56. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005.
Lietz K; Miller LW
J Am Coll Cardiol; 2007 Sep; 50(13):1282-90. PubMed ID: 17888847
[TBL] [Abstract][Full Text] [Related]
57. Frequency and impact of delayed decisions regarding heart transplantation on long-term outcomes in patients with advanced heart failure.
Lewis EF; Tsang SW; Fang JC; Mudge GH; Jarcho JA; Flavell CM; Nohria A; Givertz MM; Couper GS; Byrne JG; Warner Stevenson L
J Am Coll Cardiol; 2004 Mar; 43(5):794-802. PubMed ID: 14998619
[TBL] [Abstract][Full Text] [Related]
58. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.
Klein L; O'Connor CM; Leimberger JD; Gattis-Stough W; Piña IL; Felker GM; Adams KF; Califf RM; Gheorghiade M;
Circulation; 2005 May; 111(19):2454-60. PubMed ID: 15867182
[TBL] [Abstract][Full Text] [Related]
59. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.
Bourge RC; Abraham WT; Adamson PB; Aaron MF; Aranda JM; Magalski A; Zile MR; Smith AL; Smart FW; O'Shaughnessy MA; Jessup ML; Sparks B; Naftel DL; Stevenson LW;
J Am Coll Cardiol; 2008 Mar; 51(11):1073-9. PubMed ID: 18342224
[TBL] [Abstract][Full Text] [Related]
60. Automatic home monitoring of implantable cardioverter defibrillators.
Nielsen JC; Kottkamp H; Zabel M; Aliot E; Kreutzer U; Bauer A; Schuchert A; Neuser H; Schumacher B; Schmidinger H; Stix G; Clémenty J; Danilovic D; Hindricks G
Europace; 2008 Jun; 10(6):729-35. PubMed ID: 18434298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
